6,125 Shares in The Clorox Company $CLX Bought by Birmingham Capital Management Co. Inc. AL

Birmingham Capital Management Co. Inc. AL purchased a new position in The Clorox Company (NYSE:CLX) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 6,125 shares of the company’s stock, valued at approximately $585,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Clorox in the second quarter valued at about $958,640,000. State Street Corp raised its position in shares of Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after purchasing an additional 282,794 shares during the last quarter. Invesco Ltd. lifted its stake in Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after buying an additional 884,751 shares in the last quarter. Geode Capital Management LLC lifted its stake in Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after buying an additional 10,060 shares in the last quarter. Finally, Van ECK Associates Corp boosted its holdings in Clorox by 15.7% in the 4th quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after buying an additional 426,433 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Down 0.6%

Shares of NYSE CLX opened at $104.33 on Thursday. The stock has a market cap of $12.62 billion, a PE ratio of 21.65, a P/E/G ratio of 3.28 and a beta of 0.54. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $128.90. The company has a 50-day moving average of $99.54 and a 200 day moving average of $102.83.

Clorox (NYSE:CLX) last released its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.02. The business had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The business’s revenue was down 2.0% on a year-over-year basis. During the same period last year, the company posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts predict that The Clorox Company will post 5.8 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be given a dividend of $1.25 per share. The ex-dividend date is Wednesday, August 12th. This is a positive change from Clorox’s previous quarterly dividend of $1.24. This represents a $5.00 dividend on an annualized basis and a yield of 4.8%. Clorox’s dividend payout ratio (DPR) is 103.73%.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. UBS Group boosted their price objective on Clorox from $100.00 to $105.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 4th. Wall Street Zen lowered Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. JPMorgan Chase & Co. boosted their price target on Clorox from $92.00 to $95.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 4th. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 price target on shares of Clorox in a research report on Friday, May 1st. Finally, BNP Paribas Exane reduced their price objective on Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus target price of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.